ALYFTREK
As listed in the register: ALYFTREK
10 mg + 50 mg + 125 mg · tablet
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Vanzacaftor (Vanzacaftor Calcium) + Tezacaftor + Deutivacaftor
- Made by
- Vertex Pharmaceuticals (Canada) Incorporated
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Vertex Pharmaceuticals (Canada) Incorporated |
|---|---|
| Active substance | Vanzacaftor (Vanzacaftor Calcium) + Tezacaftor + Deutivacaftor |
| Used in | Breathing, airways, allergies and cough |
| Strength | 10 mg + 50 mg + 125 mg |
| Form | tablet |
| Classification | R07AX · Breathing, airways, allergies and cough |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02559684 |
| DPD drug code | 106281 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 4 mg + 20 mg + 50 mg
- 10 mg + 50 mg + 125 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Vanzacaftor (Vanzacaftor Calcium) + Tezacaftor + Deutivacaftor